You are on page 1of 7

New Bone Growth Substance for Treatment of Osteoporosis and Bone Fracture Healing

Hiroki Yokota, PhD Biomedical Engineering, IUPUI

Make bone strong!


ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH

www.indianactsi.org

Rationale

various stress sources stress to nutrient endoplasmic deprivation reticulum (ER) hypoxia oxidation ischemia damage/aging eIF2a phosphorylated eIF2a rest/recovery

salubrinal

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH

www.indianactsi.org

Rat Experiment
anterior surgical hole (day 20)
salubrinal injection harvest harvest

posterior hole
1 2 3 4 5 6 7 8 9 10 20 day salubrinal injection side

anterior hole

posterior cortical thickness (mm)

control salubrinal

2.000 2.0 anterior wound size (mm)

***

***

salubrinal

placebo

surgery

1.0 1

** *

1.000 1.0

0.5 0.5

0.000 0 10 days day 20 days day

0 0 days 10 day 20 days 20 day

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH

www.indianactsi.org

Selection of vehicles (RISC support)

Non toxic Good solubility

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH

www.indianactsi.org

Pharmacokinetics
subcutaneous tissue diffusion
injection molecular transport

blood circulation
molecular turnover

convection

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH

www.indianactsi.org

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH

www.indianactsi.org

Acknowledgements
Ping Zhang, IUSOM; Andy Chen, UCSD; Guofeng Wang, U. Pittsburg Matt Rubin, IURTC IU Kelly School of Business, Business of Life Sciences students

DoD Congressionally Directed Medical Research Program Teresita Bellido, Anatomy & Cell Biology, IUSOM Munro Peacock, Endocrinology, IUSOM Jeffrey Anglen, Orthopedic Surgery, IUSOM
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH

www.indianactsi.org

You might also like